Proprio's Paradigm platform clears FDA for radiation-free spine registration
A fourth clearance for Paradigm
Proprio's Paradigm platform received its fourth FDA 510(k) clearance in January 2026. The new feature, called Picasso, expands the platform's surgeon-controlled registration workflow.
Registration without radiation
Picasso uses trace-based optical registration instead of CBCT spins. Surgeons verify and refine spine alignment directly, without pausing to restart the workflow.
Where Picasso fits
Paradigm already provides continuous three-dimensional measurement of spinal alignment during surgery. Picasso extends that capability across a broader range of spine procedures, giving surgeons direct control over registration at the point of care.
What it replaces
The feature targets two standard steps in spine navigation: CBCT-based registration and technician-led setup. Proprio positions Picasso as an alternative to both.
The bigger picture
Paradigm combines computer vision, light-field imaging, and AI to build a continuous three-dimensional view of the surgical field. Picasso is Proprio's fourth cleared capability on that platform since its first clearance in 2023.
Source: Proprio
